![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication September 14, 2004.
Revised October 19, 2004.
Accepted for publication October 20, 2004.
,23S,25-trihydroxyvitamin D3 by human UDP-glucuronosyltransferase 1A3
26,26,26,27,27,27-Hexafluoro-1
,25-dihydroxyvitamin D3 (F6-1,25(OH)2D3), which is now clinically used as a drug for secondary hyperparathyroidism, is a hexafluorinated analog of the active form of vitamin D3. Our previous studies demonstrated that CYP24A1 is responsible for the metabolism of F6-1,25(OH)2D3 in the target tissues, and that F6-1,25(OH)2D3 was successively converted to F6-1,23S,25(OH)3D3, and F6-23-oxo-1,25(OH)2D3. In this study, we examined the metabolism of F6-1,25(OH)2D3, F6-1,23S,25(OH)3D3, and F6-23-oxo-1,25(OH)2D3 by human UDP-glucuronosyltransferases (UGTs). Of these compounds, F6-1,23S,25(OH)3D3 was remarkably glucuronidated both in human liver microsomes and in the recombinant system expressing human UGT. No significant interindividual differences were observed among ten human liver samples. The recombinant system for 12 species of human UGTs revealed that F6-1,23S,25(OH)3D3 glucuronidation was specifically catalyzed by UGT1A3. The information obtained in this study appears quite useful to predict the metabolism and efficacy of vitamin D analogs in human bodies before clinical trials. In addition, note that for the first time a possible probe substrate for UGT1A3 has been found.
Key words:
cytochrome P450, kinetics, UDP glucuronyltransferases, vitamin D
This article has been cited by other articles:
|
|
 |
|
  Y. Kato, S.-i. Ikushiro, Y. Emi, S. Tamaki, H. Suzuki, T. Sakaki, S. Yamada, and M. Degawa Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans Drug Metab. Dispos., January 1, 2008; 36(1): 51 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mano, T. Usui, and H. Kamimura The UDP-Glucuronosyltransferase 2B7 Isozyme Is Responsible for Gemfibrozil Glucuronidation in the Human Liver Drug Metab. Dispos., November 1, 2007; 35(11): 2040 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mano, T. Usui, and H. Kamimura Predominant Contribution of UDP-Glucuronosyltransferase 2B7 in the Glucuronidation of Racemic Flurbiprofen in the Human Liver Drug Metab. Dispos., July 1, 2007; 35(7): 1182 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wen, D. E. Martin, P. Bullock, K.-H. Lee, and P. C. Smith Glucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species Differences Drug Metab. Dispos., March 1, 2007; 35(3): 440 - 448. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
